Updates

Strix

August 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Strix has continued to perform well during H1 confirming it is on track to meet full year expectations. During the period, it maintained its global market leading share of c.38% with the US showing particularly good growth in Regulated Markets and early indications suggest that the new U9 product will drive market share in Less Regulated Markets. Aqua Optima experienced a strong performance on the back of contract wins with major UK retailers and achieved c.20%, a record level. Broker Zeus forecasts eps of 12.4p for the current year and 13.5p next. Written about at 127p in September ‘17, the shares have done well. Hold but insert stoploss at 160p. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Simplybiz - Advisor membership ahead of forecast

EMIS - Cash climbs to £32m

Strix (November 2024)

Strix (August 2023)

Strix (January 2023)

Strix - Buys Billi for £38m (November 2022)

Strix (October 2022)

Strix (August 2022)

Strix - Faster growth from water and SDA divisions (October 2021)

Strix (August 2021)

Strix - Strategy to double sales by 2025 (May 2021)

Strix (October 2019)

Strix (May 2018)

Strix - Whos who of institutional buyers (September 2017)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X